A Framework for Inferring and Analyzing Pharmacotherapy Treatment Patterns
Rush, E.; Ozmen, O.; Kim, M.; Ortegon, E. R.; Jones, M.; Park, B. H.; Pizer, S.; Trafton, J.; Brenen, L.; Ward, M.; Nebeker, J. R.
Show abstract
ObjectiveTo discover pharmacotherapy prescription patterns and their statistical associations with outcomes through a clinical pathway inference framework applied on real-world data. Materials and MethodsWe apply machine learning steps in our framework using a 2006 to 2020 cohort of veterans with major depressive disorder (MDD). Outpatient antidepressant pharmacy and emergency department visits, self-harm, and all-cause mortality data were extracted from the Department of Veterans Affairs Corporate Data Warehouse. ResultsOur MDD cohort consisted of 252,179 individuals. During the study period there were 98,417 cases of emergency department visits, 1,016 cases of self-harm, and 1,507 deaths from all causes. The top ten prescription patterns accounted for 69.3% of the data for individuals starting antidepressants at the fluoxetine equivalent of 20-39mg. Additionally, we found associations between outcomes and dosage change. DiscussionFor 252,179 Veterans who served in Iraq and Afghanistan with subsequent MDD noted in their electronic medical record, we documented and described the major pharmacotherapy prescription patterns implemented by VHA providers. Ten patterns accounted for almost 70% of the data. Associations between antidepressant usage and outcomes in observational data may be confounded. The low numbers of adverse events especially associated with all-cause mortality make our calculations imprecise. Furthermore, our outcomes are also the indications for both disease and treatment. Despite these limitations, we demonstrate the usefulness of our framework in providing operational insight into clinical practice, and our results underscore the need for increased monitoring during critical points of treatment.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Developing A Deep Learning Natural Language Processing Algorithm For Automated Reporting Of Adverse Drug Reactions 93%
- Automated Interpretable Discovery of Heterogeneous Treatment Effectiveness: A Covid-19 Case Study 92%
- Using computable knowledge mined from the literature to elucidate confounders for EHR-based pharmacovigilance 92%
Similar papers in this journal
Similar papers in this journal
- Using explainable machine learning to identify patients at risk of reattendance at discharge from emergency departments 92%
- Scalable Incident Detection via Natural Language Processing and Probabilistic Language Models 92%
- Improving ascertainment of suicidal ideation and suicide attempt with natural language processing 92%
Similar papers in this journal
- Practical barriers and facilitators experienced by patients, pharmacists and physicians to the implementation of pharmacogenomic screening in Dutch outpatient hospital care – an explorative pilot study 91%
- The Contribution of Pharmacogenetic Drug Interactions to 90-Day Hospital Readmissions: Preliminary Results from a Real-World Healthcare System 89%
- Pharmacogenomic and drug interaction risk associations with hospital length of stay among Medicare Advantage members with COVID-19 87%
Similar papers in this journal
- Clinical trial emulation can identify new opportunities to enhance the regulation of drug safety in pregnancy 91%
- Pretrained Patient Trajectories for Adverse Drug Event Prediction Using Common Data Model-based Electronic Health Records 91%
- Systematic Review of Large Language Models for Patient Care: Current Applications and Challenges 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.